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Abstract
Background: Cognitive impairment occurs in about 50% of multiple sclerosis (MS) patients, and the use of self-reported
outcomes for evaluating treatment and managing care among subjects with cognitive dysfunction has been questioned.
The aim of this study was to provide new evidence about the suitability of self-reported outcomes for use in this specific
population by exploring the internal structure, reliability and external validity of a specific quality of life (QoL) instrument,
the Multiple Sclerosis International Quality of Life questionnaire (MusiQoL).
Methods: Design: cross-sectional study. Inclusion criteria: MS patients of any disease subtype. Data collection:
sociodemographic (age, gender, marital status, education level, and occupational activity) and clinical data (MS subtype,
Expanded Disability Status Scale, disease duration); QoL (MusiQoL and SF36); and neuropsychological performance (Stroop
color-word test). Statistical analysis: confirmatory factor analysis, item-dimension correlations, Cronbach’s alpha coefficients,
Rasch statistics, relationships between MusiQoL dimensions and other parameters.
Principal Findings: One hundred and twenty-four consecutive patients were enrolled. QoL scores did not differ between
the 69 cognitively non-impaired patients and the 55 cognitively impaired patients, except for the symptoms dimension. The
confirmatory factor analysis performed among the impaired subjects showed that the structure of the questionnaire
matched with the initial structure of the MusiQoL. The unidimensionality of the MusiQoL dimensions was preserved, and the
internal validity indices were satisfactory and close to those of the reference population.
Conclusions/Significance: Our study suggests that executive dysfunction did not compromise the reliability and the validity
of the self-reported QoL questionnaires.
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Introduction
Measures of health-related quality of life (HRQoL) are being
used with increasing frequency in the treatment of multiple
sclerosis (MS) as an outcome measure for assessing disease
progression, evaluating treatment and managing care [1,2]. While
regulatory authorities and clinicians request this type of informa-
tion, HRQoL remains rarely used in clinical practice to adjust the
management of the patient care because assessment of HRQoL is
suspected of containing some limitations [3].
The use of self-reported outcomes among subjects with
cognitive dysfunction is of particular concern [3]. While cognitive
impairment occurs in about 50% of MS patients [4,5], even during
the early stages of the disease [6,7], the extent to which MS
patients with cognitive dysfunction can validly self-report their
quality of life (QoL) is a crucial issue that remains insufficiently
examined. The main argument against using self-reported QoL
information from patients with cognitive dysfunction was based on
the fact that the QoL instruments were not developed among these
specific individuals. Although there is a little evidence concerning
the reliability and validity of health status measures in cognitively
impaired patients [3], two perspectives have been presented.
While some authors have argued that individuals with cognitive
impairment are not able to produce valid QoL measures [4,8],
others reported some empirical evidence suggesting that individ-
uals with a moderate degree of cognitive impairment can perform
reliable HRQoL assessments [9–11]. Most of the studies provided
information about patients with severe mental disorders [12–15]
or older populations [16] presenting with dementia or other severe
cognitive impairment [16–18]. To our knowledge, only two main
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studies have reported data from MS patients [10,11]. These results
suggested that cognitive decline does not compromise the reliable
and valid assessment of self-reported health measures. These
studies did not report how the factorial structure described in the
impaired samples fit with the initial structure of the tested
instrument, which is a key point when considering validity in these
specific populations.
To provide new evidence about the suitability for using self-
reported QoL information in this specific population, we propose
to explore the internal structure, reliability and external validity of
a specific QoL instrument, the Multiple Sclerosis International
Quality of Life questionnaire (MusiQoL), exclusively developed
from the patients’ point-of-view [19]. The study sample includes
MS subjects with or without cognitive impairment. The MusiQoL
is a self-administered, disease-specific QoL instrument that is
available in 14 languages [20–23].
Methods
This study relied on a cross-sectional design and was performed
in the neurology department of a French public academic teaching
hospital (Marseille, France). The inclusion criteria were as follows:
patient with MS diagnosis according to McDonald criteria [24],
any disease subtype, no history of psychiatric or neurological
disease (other than MS), no history of alcohol/drug abuse, and
native French speaker. The French Ethics Committee (Comite´ de
Protection des Personnes Marseille II) approved the study, and
patients gave their informed consent to participate. Sociodemo-
graphic (age, gender, marital status, education level, and
occupational activity) and clinical (MS subtype and disease
duration) data for each patient were recorded. The MS disability
was assessed using the Expanded Disability Status Scale (EDSS).
HRQoL was assessed by means of the MusiQoL. The MusiQoL
is a well-validated questionnaire that describes the following nine
dimensions and yields a global index score: activity of daily living
(ADL), psychological well-being (PWB), symptoms (SPT), rela-
tionships with friends (RFr), relationships with family (RFa),
relationships with health care system (RHCS), sentimental and
sexual life (SSL), coping (COP), and rejection (REJ). HRQoL
assessment was completed using the Short Form 36 (SF36), which
is a generic questionnaire [25] describing eight subscales (physical
function, social functioning, role physical, role emotional, mental
health, vitality, bodily pain, and general health). Two composite
scores (physical and mental, PCS-SF36 and MCS-SF36) were also
calculated.
Neuropsychological performance was assessed using the carded-
based version of the Stroop color-word test [26]. We used the
more widespread version including 3 subtests: 1) the color naming
subtest where the subject was instructed to name the color of a
string of dots; 2) the word naming subtest where the subject was
instructed to read a list of words indicating colors printed in black
letters; and 3) the color-word naming subtest where the subject
had to name the color of the letters of color words printed in
different colors. Performance was assessed by calculating the time
required to name 100 items in each trial (higher scores indicate
worse performance). The test was administered in a standardized
manner by the same psychologist (FR) who was intensively trained
in test administration. The same instructions were given to the
subjects prior to each trial.
For each subtest, the subject was defined as impaired or non-
impaired by applying French normative values [27] according to
age and educational level. Patients were categorized into the
following categories according to cognitive function as measured
by the Stroop test: a) cognitively non-impaired group (3 normal
subtests); b) cognitively impaired group (one or more abnormal
subtests).
Statistical analyses
Statistical analyses were performed to explore the internal
structure, reliability and external validity of the MusiQoL. The
exploration of the psychometric properties of a questionnaire was
largely described in the specific literature. The definitions of the
main psychometric properties were summarized in the Figure 1.
Statistical analyses were performed on the two groups defined
above using the same procedure reported in the initial validation
publication (reference population), except for factor analysis
(confirmatory instead exploratory).
The structures of the MusiQoL, both in the non-impaired and
impaired groups, were explored using confirmatory factor analysis
to determine how these structures matched with the initial
structure of the MusiQoL issued of a principal component factor
analyses with varimax rotation. Kaiser-Meyer-Olkin (KMO)
measures of sample adequacy of the model for the residual
matrices were computed: if the KMO index was higher than 0.50,
then a factor analysis of the residual matrix was performed.
The multidimensional structure (construct validity) of the
version was checked using the multi-trait/multi-item analysis
program [28]. Internal structural validity was assessed by
investigating item-dimension correlations. Item internal consisten-
cy (IIC) was assessed by correlating each item with its scale, and
item discriminant validity (IDV) was assessed by determining the
extent to which items correlated with the dimension they were
hypothesized to represent as compared to correlations with other
dimensions. Floor and ceiling effects were reported to assess the
homogeneous repartition of the response distribution (effects lower
than 10% are expected). For each dimension, internal consistency
reliability was evaluated by Cronbach’s alpha coefficient [29]; the
values of which were compared between the non-impaired and
impaired groups using the alpha test program [30].
The unidimensionality of each scale was explored by compu-
tation of item goodness-of-fit statistics (INFIT) issued from Rasch
analyses [31]. INFIT values ranging from 0.7 to 1.2 ensure that all
the items of the scale tend to measure the same concept.
Differential item functioning (DIF) analyses were performed,
comparing the item difficulties between the two groups according
to the cognitive status (non-impaired, impaired) to check whether
all the items behave the same way [31]. DIF means that an item
performs and measures differently for one subgroup of a
population than for another.
To explore external validity, Spearman’s correlation coefficients
were used to investigate relationships between dimensions of the
MusiQoL and SF36 in each group, and the associations between
the MusiQoL dimension scores and sociodemographic and clinical
features were reported. For qualitative variables, mean dimension
scores of the MusiQoL were compared across patient groups that
were expected to differ (e.g., gender, educational level, marital
status, and occupational status) using one-way analysis of variance.
Quantitative variables (e.g., age, EDSS score, and MS duration)
were analyzed using Spearman’s correlation coefficients. The
underlying assumption was that the strength of the relationships
would be similar for both groups (non-impaired and impaired) and
the reference population. Comparisons of correlation coefficients
were performed [32].
Acceptability was assessed by calculating the percentage of
missing data per dimension.
Data analyses were performed using SPSS 11.0, MAP-R,
LISREL and WINSTEP software.
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Results
One hundred and twenty-four consecutive patients were
enrolled. The mean age was 45 years (SD 11), 57.3% of the
patients were women, and 47.2% had more than 12 years of
education. The MS subtypes included 61 secondary progressive,
36 relapsing remitting, 20 primary progressive, and 7 clinically
isolated syndromes. From the French normative values [27],
performances on Stroop subtests varied from 24 to 28% (24.1%
impaired for the color naming subtest, 26.5% for the word naming
subtest, and 28.0% for the color-word naming subtest). The
definition of cognitive status classified 69 patients as cognitively
non-impaired and 55 (44.3%, 95% confidence interval 35.6–53.0)
as cognitively impaired.
MusiQoL scores
The mean dimension scores and indices did not differ between
the non-impaired and impaired subjects except for the symptoms
dimension, with higher scores among the non-impaired subjects
(Figure 2). Missing values were higher in the impaired group but
never exceeded 10% (range from 4.8 to 10.0%). Details are
presented in table 1.
Construct validity
The 9-factor structure of the MusiQoL accounted for 73.4% of
the total variance among the non-impaired patients and for 77.3%
among the impaired patients.
In the non-impaired group, the 9-factor structure was clearly
retrieved. Only 3 of the 31 items contributed to a second factor
without being major contributors. In the impaired group, only
8 of the 9 initial factors were identified. Two items (numbers
28 and 29) that belonged to the rejection dimension in the
initial structure contributed to another factor: the psycholog-
ical well-being dimension, which is close to the rejection
dimension. All other items mainly contributed to their initial
dimension, except item number 15, which was initially caught
by the symptoms dimension. The content analysis of the new
isolated factor (factor 4) did not identify a specific meaning,
grouping both psychological well-being and rejection dimen-
sions. These structures appear acceptable and are presented in
the table S1.
Internal structural validity was satisfactory for all dimensions
in the two groups; each item achieved the 0.40 standard for
IIC. The correlation for each item with its contributive
dimension was higher than with the others (IDV), except for
two dimensions (i.e., activity of daily living and psychological
well-being) in the impaired group. Floor effects were less than
10%, except in the sentimental and sexual life dimension
(18.8% among non-impaired subjects and 22.0% among
impaired, respectively). The wrong ceiling effects were pro-
duced for the rejection dimension, 25.0 and 44.0% respectively.
Cronbach’s alpha coefficients ranged from 0.63 to 0.88 in the
non-impaired group, and from 0.64 to 0.90 in the impaired
group, indicating satisfactory internal consistency. No statistical
differences were found between the non-impaired and impaired
groups using Cronbach’s alpha. For 6 of the 9 dimensions, no
items showed an INFIT statistic outside the acceptable range;
items were outside the acceptable range for activity of daily
living in both groups, for relationships with friends in the non-
impaired group, and for psychological well-being in the
impaired group. All results are detailed in table 1. According
to the definition of DIF, there should be no association between
the item and the cognitive status, showing that MusiQoL
dimensions are relevant whatever the cognitive status (this was
the case only for item number 15 with p,0.05, data not
shown).
Figure 1. Psychometric properties of a QoL questionnaire: definitions.
doi:10.1371/journal.pone.0030627.g001
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External and discriminant validity
Spearman’s correlation coefficients between MusiQoL and
SF36 scores are provided in the table S2. The concepts covered
by the MusiQoL and the SF36 are not strictly overlapping. The
social functioning domain did not correlate with ‘relationships-like’
dimensions of MusiQoL. As expected, the mental health
dimension and mental composite score of the SF36 were mainly
statistically associated with the psychological well-being dimension
of the MusiQoL, while physical functioning, vitality, bodily pain,
general health and physical composite score of SF36 correlated
more strongly with the activity of daily living dimension of the
MusiQoL, across all cognitive groups. Among the 100 tested
correlations, only 80% of them were not statistically different
between the non-impaired and impaired groups (results not
reported). As expected, few significant correlations were found
between MusiQoL scores and MS duration or EDSS, except for
EDSS, which highly correlated with activity of daily living in the
non-impaired group. Contrarily, the age of patients was not linked
to activity of daily living. These results are detailed in table 2. As
expected, the women in this study reported lower psychological
well-being scores than the men, and single subjects reported lower
sentimental and sexual life and index scores than subjects having a
partner among both non-impaired and impaired individuals
(table 3).
Discussion
While the assessment of quality of life in MS has received
increasing recognition as an outcome parameter in MS research,
one should consider whether self-reported information remains
reliable when patients experience cognitive problems and to what
extent HRQoL measurement remains valid in such a context.
Therefore, it seems absolutely necessary to check if the initial
internal structure of the self-reported measure is well adapted
when HRQoL measures will be used for cognitively impaired
individuals and to confirm if the psychometric properties are
satisfactory in these populations [3].
Our results provide strong arguments to support the conclusion
that cognitively impaired MS patients, as defined from an
executive dysfunction, are reliable and consistent when answering
the MusiQoL questionnaire. First, the confirmatory factor analysis
showed that the structure performed among the impaired subjects
almost matched with the initial structure of the MusiQoL. Overall,
8 of the 9 dimensions were clearly identified. Items describing the
predefined rejection dimension mainly contributed to the
psychological well-being dimension. The limitation regarding the
relative small size of the sample and the meaning of the items
describing this rejection dimension which are not so fairly distant
to the items constituting the psychological well-being dimension
should be noted. This last point can be supported by the
examination of the moderate correlation between the 2 dimen-
sions issued of the initial validation (r = 0.39, p,0.001, data not
shown in the initial publication) [19]. However, the unidimen-
sionality of each of these dimensions seemed ensured by the
satisfactory INFIT statistics. Moreover, IIC and IDV values
reported in the impaired group were very close to those of the
reference population, and similar to those of the non-impaired
sample. Internal consistency coefficients, despite the patient’s
cognitive status, were near to the initial reference population,
except for the coping dimension (which presented a less
satisfactory coefficient). Floor and ceiling effects were similar to
those reported in the initial validation publication, except for the
Figure 2. Means of dimension/index scores of MusiQoL according to the cognitive status.
doi:10.1371/journal.pone.0030627.g002
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floor effect which was higher for sentimental and sexual life in both
the impaired and non-impaired groups. This was probably due to
the specificity of the French sample, whereas reference values were
issued from patients from 14 countries including North-American
subjects. Indeed, it is now well-known that the populations of south
Europe more easily accept sexuality as a normal part of life than
do North-American populations [33]. Lastly, no difference was
found for item functioning, whatever the cognitive status,
indicating the relevance of the structure.
Otherwise, the MusiQoL scores of both groups were consistent
with those of the SF36 as compared to the reference population.
As expected, activity of daily living was strongly linked to the
‘physical-like’ dimensions of SF36 (including the physical com-
posite score), and psychological well-being was highly correlated to
the ‘psychological-like’ dimensions of SF36 (including the mental
composite score). These findings support the validity of the
MusiQoL in altered and non-altered patients adding information
not covered by the generic questionnaires [34].
However, some limitations should be considered. The sample
size was small but similar to other studies [10,11]. The
representativeness of our sample should also be noted. Our
patients had a more severe disability profile and a higher
proportion of secondary progressive disease as compared to
international and European MS populations [19,35]. However,
the proportion of cognitively impaired subjects, 44%, was in
accordance with the literature [4,5] and was similar to other
studies with like objectives [10,11]. Nevertheless, the present study
did not focus on the most severe cases because patients with
dementia or those unable to be assessed using neuropsychological
tests were not included.
Another important aspect of this study regards our definition of
cognitive dysfunction. Indeed, cognition can be defined as a mental
process of knowing, including aspects such as awareness, perception,
reasoning, and judgment. Several theoretical approaches to the
definition of cognitive impairment can be implemented [36]. The
‘all or none’ approach is based on existence or absence of an
abnormality. Another approach is an epidemiologically (or
‘categorically’) based approach [37], which determines that
cognitive domains affected in MS patients may be similar between
individuals. We arbitrarily restricted cognitive function to its
composite executive function to produce additional insight as
compared to the two main studies reporting similar data, which
focused on memory assessment. Cognitive impairment was defined
from the Symbol Digit Modalities Test (SDMT) [11] and from both
the Wechsler Adult Intelligence Scale (WAIS-III) and the Wechsler
Memory Scale (WMS-III) [10]. Considering just one composite
would not have been a perfect reflection of a global cognitive
function. It would have been misleading to assume that our patients
were not suffering from other neuropsychological deficits [38]. It has
been well documented in previous studies that it would be unusual
to observe executive deficits in isolation [39,40] and that HRQoL
measurement may be altered differently depending on the kind of
cognitive impairment in patients [41]. Executive dysfunction is a
frequent finding in MS patients, even at the early stage of the
disease. On a psychometric point of view, a recent meta-analysis
reported than Stroop word and color test was a more sensitive task
to detect executive dysfunction in MS [42]. Future studies could
provide further information according to other definitions of
cognitive dysfunction integrating combination of different compos-
ites (i.e., memory, attention, and concentration).
In the same way as defining executive dysfunction from one test,
the Stroop test can also be biased. Because the test requires the use
of different cognitive functions such as memory, concentration and
executive functions, individuals with different incapacities can be
categorized in the same group although they do not present the
same deficit [43]. First, while this test is recognized as a good
performance tool to assess inhibition ability, general speed of
processing [27], and attention performance [44], executive
function can include other components such as working memory,
initiation and inhibition of responses, strategy planning and
conceptual activity, which are insufficiently assessed by the Stroop
test. Second, while this test is considered as a standardized
neuropsychological instrument, several procedural variations and
performance reports are available leading to various interpreta-
tions [45,46]. Our choice to implement this test relied on the
following points: i) the high sensitivity of the test [47]; ii) the recent
availability of French norms, taking account age and educational
level effects [48], eliminating the need for a control group [49]; iii)
Table 2. Correlations between MusiQoL, age and clinical features according to the cognitive status.
ADL PWB RFr SPT RFa RHCS SSL COP REJ index
Age NI 20,04 0,21 0,14 0,01 20,10 0,10 20,07 0,26* 0,28* 0,18
I 20,07 0,02 0,06 0,20 0,08 0,08 20,07 0,08 20,06 0,08
Ref 20,33** 20,01 0,01 20,14** 20,03 0,00 20,13** 0,00 20,05* 20,13**
EDSS NI 20,56** 0,12 0,23 0,01 0,00 20,17 20,06 20,04 0,19 0,05
I 20,16 0,04 0,14 0,26 0,13 20,08 0,08 0,11 0,12 0,15
Ref 20,65** 20,04 20,03 20,19** 20,01 20,11** 20,19** 20,13** 20,25** 20,32**
MS duration NI 20,13 20,18 0,09 20,16 20,33** 20,07 20,16 0,04 0,09 20,17
I 0,14 0,12 0,10 0,29* 0,08 0,13 0,16 20,01 0,12 0,29*
Ref 20,02 0,01 0,03 20,07** 20,05 0,00 20,05 0,00 0,07** 20,04
ADL activity of daily living, PWB psychological well-being, RFr relationships with friends, SPT symptoms, RFa relationships with family, RHCS relationships with health
care system, SSL sentimental and sexual life, COP coping, REJ rejection.
NI non-impaired, I impaired, Ref reference population.
Spearman rank correlation coefficients were presented.
Bold values: p,0,05,
*p-value,0,05,
**p-value,0,01.
Italic characters: reference population values.
doi:10.1371/journal.pone.0030627.t002
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the existing relationships between Stroop performance and QoL
[43]; iv) the frequency of impairment of the Stroop performance in
MS population [50]; and v) the cultural robustness, including a
French language version [51].
Our study confirms preliminary results reported from two
similar previous studies using different QoL measurements and
suggesting that executive dysfunction did not compromise the
reliable and valid assessment of self-reported health measures.
These robust results will be confirmed by performing other
cognitive composites, such as memory or attention, among more
severely affected individuals. If these findings will be confirmed,
assessment of QoL in MS patients could be more widely used
without fear of inadequacy of this approach in those patients with
cognitive impairment.
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